Cargando…

Cellular and Molecular Mechanisms of Anterior Chamber-Associated Immune Deviation (ACAID): What We Have Learned from Knockout Mice

Anterior chamber-associated immune deviation (ACAID) is a well-known phenomenon that can occur after an antigen is introduced without any danger signal into the anterior chamber of a murine eye. It is reported to lead to an antigen-specific immune deviation throughout the body. Despite the relativel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vendomèle, Julie, Khebizi, Quentin, Fisson, Sylvain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714853/ https://www.ncbi.nlm.nih.gov/pubmed/29250068 http://dx.doi.org/10.3389/fimmu.2017.01686

Ejemplares similares

Subretinal Injection of HY Peptides Induces Systemic Antigen-Specific Inhibition of Effector CD4(+) and CD8(+) T-Cell Responses
por: Vendomèle, Julie, et al.
Publicado: (2018)

Anterior Chamber-Associated Immune Deviation (ACAID): An Acute Response to Ocular Insult Protects from Future Immune-Mediated Damage?
por: Cone, Robert E., et al.
Publicado: (2009)

Does anterior chamber-associated immune deviation (ACAID) play a role in posterior lamellar keratoplasty? Case report of a splenectomized patient
por: Hos, Deniz, et al.
Publicado: (2019)

The Induction of Circulating, ACAID-Inducing Monocytes Requires CCR2/CCL2-Dependent Migration of Circulating F4/80(+) Cells into the Anterior Chamber
por: Cone, Robert E, et al.
Publicado: (2010)

What We Have Learned and What We Have Missed in Tuberculosis Pathophysiology for a New Vaccine Design: Searching for the “Pink Swan”
por: Cardona, Pere-Joan
Publicado: (2017)

Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?
por: Marshall, Michael J. E., et al.
Publicado: (2017)

Induction of anterior chamber-associated immune deviation requires an intact, functional spleen
Publicado: (1981)

What Have We Learnt about BCG Vaccination in the Last 20 Years?
por: Dockrell, Hazel M., et al.
Publicado: (2017)

B-Cell Dysregulation in Idiopathic Nephrotic Syndrome: What We Know and What We Need to Discover
por: Colucci, Manuela, et al.
Publicado: (2022)

Immunoglobulin M in Health and Diseases: How Far Have We Come and What Next?
por: Jones, Katelyn, et al.
Publicado: (2020)

Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently?
por: Lv, Yue, et al.
Publicado: (2022)

Upregulation of CD94 on CD8(+)T Cells in Anterior Chamber-Associated Immune Deviation
por: He, Hao, et al.
Publicado: (2008)

The role of ACAID and CD4(+)CD25(+)FOXP3(+) regulatory T cells on CTL function against MHC alloantigens
por: Saban, Daniel R., et al.
Publicado: (2008)

A penetrating ocular injury can affect the induction of anterior chamber–associated immune deviation
por: Lei, Fang, et al.
Publicado: (2008)

Narcolepsy and H1N1 influenza immunology a decade later: What have we learned?
por: Buonocore, Sofia M., et al.
Publicado: (2022)

Influence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models
por: Galand, Claire, et al.
Publicado: (2012)

Anterior chamber associated immune deviation used as a neuroprotective strategy in rats with spinal cord injury
por: Pineda-Rodriguez, Beatriz, et al.
Publicado: (2017)

PTH Assays: Understanding What We Have and Forecasting What We Will Have
por: Vieira, Jose Gilberto H.
Publicado: (2012)

Lymph Node Cellular Dynamics in Cancer and HIV: What Can We Learn for the Follicular CD4 (Tfh) Cells?
por: Poultsidi, Antigoni, et al.
Publicado: (2018)

Immune responses to Tilapia lake virus infection: what we know and what we don’t know
por: Kembou-Ringert, Japhette E., et al.
Publicado: (2023)

Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer?
por: Blackburn, Anneke C, et al.
Publicado: (2002)

Immune Deviation in the Decidua During Term and Preterm Labor
por: Zha, Ying, et al.
Publicado: (2022)

Steroid-Refractory Gut Graft-Versus-Host Disease: What We Have Learned From Basic Immunology and Experimental Mouse Model
por: Song, Qingxiao, et al.
Publicado: (2022)

Innate immunity and chronic rhinosinusitis: What we have learned from animal models
por: London, Nyall R., et al.
Publicado: (2016)

What have we learned?
por: Rodgers, Peter, et al.
Publicado: (2021)

Tregs: Where We Are and What Comes Next?
por: Zhao, Hai, et al.
Publicado: (2017)

Psychological Interventions for Dementia Caregivers: What We Have Achieved, What We Have Learned
por: Cheng, Sheung-Tak, et al.
Publicado: (2019)

Lipoabdominoplasty: What We Have Implemented and What We Have Modified over 26 Years
por: Cárdenas-Camarena, Lázaro, et al.
Publicado: (2023)

Increased expression of Foxp3 in splenic CD8(+) T cells from mice with anterior chamber-associated immune deviation
por: Jiang, Liqiong, et al.
Publicado: (2007)

Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
por: Alkilany, Alaaldin M., et al.
Publicado: (2010)

Immunity to Avian Leukosis Virus: Where Are We Now and What Should We Do?
por: Feng, Min, et al.
Publicado: (2016)

Population Equation: Balancing What We Need With What We Have
por: Dahl, Richard
Publicado: (2005)

Reversal Agents: What We Have and What We Can Expect
por: Ruff, Christian T.
Publicado: (2018)

Artificial Intelligence in Urooncology: What We Have and What We Expect
por: Froń, Anita, et al.
Publicado: (2023)

Low Anterior Resection Syndrome: What Have We Learned Assessing a Large Population? †
por: Dulskas, Audrius, et al.
Publicado: (2022)

Neutrinos, what we have learned about them and what we have learned using them
por: Steinberger, J
Publicado: (2013)

Retroviruses As Myeloid Cell Riders: What Natural Human Siglec-1 “Knockouts” Tell Us About Pathogenesis
por: Martinez-Picado, Javier, et al.
Publicado: (2017)

Large Extracellular Vesicles: Have We Found the Holy Grail of Inflammation?
por: Słomka, Artur, et al.
Publicado: (2018)

Rodent models of postherpetic neuralgia: How far have we reached?
por: Ou, Mingxi, et al.
Publicado: (2023)

What role for cellular metabolism in the control of hepatitis viruses?
por: Diaz, Olivier, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m8cggsfjhogrounmahu4thh5m5